Arcturus Therapeutics Holdings Inc. - COMMON STOCK (ARCT)

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class
Equity / COMMON STOCK
Shares outstanding
28,406,191
Total 13F shares
18,286,626
Share change
+711,726
Total reported value
$287,821,556
Put/Call ratio
46%
Price per share
$15.74
Number of holders
114
Value change
+$9,614,039
Number of buys
58
Number of sells
40

Institutional Holders of Arcturus Therapeutics Holdings Inc. - COMMON STOCK (ARCT) as of Q2 2022

As of 30 Jun 2022, Arcturus Therapeutics Holdings Inc. - COMMON STOCK (ARCT) was held by 114 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 18,286,626 shares. The largest 10 holders included FEDERATED HERMES, INC., STATE STREET CORP, BlackRock Inc., Sumitomo Mitsui Trust Holdings, Inc., VANGUARD GROUP INC, FMR LLC, Point72 Asset Management, L.P., GEODE CAPITAL MANAGEMENT, LLC, GOLDMAN SACHS GROUP INC, and JPMORGAN CHASE & CO. This page lists 114 institutional shareholders reporting positions in this security for the Q2 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.